COVID-19 Seroprevalence Study: For Official Department of Defense Use Only
November 2024, the Department of Defense (DOD) engaged in a longitudinal SARS-CoV-2 (coronavirus) seroprevalence study of 29,000 members of the U.S. military between May 2020 and June 2021. Active, Guard, and Reserve components were included in the study.
Each document is marked “For Official Use Only” or “Controlled Unclassified Information” in a preventative measure to avoid being released outside of DOD.
Despite the risk, the revealing documents were provided to Children’s Health Defense by an unnamed military whistleblower.
https://static1.squarespace.com/static/63c72440d8b76f41002cffc6/t/675c6bda4a972e1bc3a83db1/1734110195497/Seroprevalence+Study+Merged+PDF.pdf